New fund targets companies battered by market doubts
Record low biotech valuations have prompted a new VC investor to start shopping with a planned $200 million fund.
Source: afr.com
Stay updated with breaking news from Genera Biosystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Record low biotech valuations have prompted a new VC investor to start shopping with a planned $200 million fund.
/PRNewswire/ -- The "Human Papillomavirus Testing Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19"...